GHP Investment Advisors Inc. Reduces Holdings in Synopsys, Inc. $SNPS

GHP Investment Advisors Inc. reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 9.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,839 shares of the semiconductor company’s stock after selling 1,893 shares during the period. GHP Investment Advisors Inc.’s holdings in Synopsys were worth $7,469,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of SNPS. Sankala Group LLC purchased a new stake in shares of Synopsys in the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys in the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd acquired a new position in Synopsys in the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys in the 4th quarter valued at about $32,000. Finally, Phillip James Consulting Co. acquired a new stake in shares of Synopsys during the 4th quarter worth about $36,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

SNPS opened at $455.02 on Friday. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73. The company’s 50 day simple moving average is $483.35 and its 200 day simple moving average is $462.20. The stock has a market capitalization of $87.13 billion, a PE ratio of 105.33, a P/E/G ratio of 2.73 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter last year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Citigroup boosted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $450.00 to $550.00 in a research report on Tuesday. Rosenblatt Securities lifted their target price on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Berenberg Bank set a $633.00 price target on Synopsys in a research note on Wednesday, May 27th. Finally, BNP Paribas Exane raised their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Ten investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average target price of $570.06.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.